Bgb-A425, An Investigational Anti-Tim-3 Monoclonal Antibody, In Combination With Tislelizumab, An Anti-Pd-1 Monoclonal Antibody, In Patients With Advanced Solid Tumors: A Phase I/Ii Trial In Progress.

Jayesh Desai,Tarek Meniawy,Brandon Beagle,ZheZhen Li,Song Mu,John Wu,Crystal S. Denlinger,Wells A. Messersmith

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 8|浏览20

暂无评分

摘要

TPS3146Background: While immune surveillance plays a critical role in preventing tumor proliferation and metastasis, tumors develop resistance mechanisms to suppress and/or escape the immune system...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要